this post was submitted on 31 May 2024
225 points (99.1% liked)

World News

38979 readers
3188 users here now

A community for discussing events around the World

Rules:

Similarly, if you see posts along these lines, do not engage. Report them, block them, and live a happier life than they do. We see too many slapfights that boil down to "Mom! He's bugging me!" and "I'm not touching you!" Going forward, slapfights will result in removed comments and temp bans to cool off.

We ask that the users report any comment or post that violate the rules, to use critical thinking when reading, posting or commenting. Users that post off-topic spam, advocate violence, have multiple comments or posts removed, weaponize reports or violate the code of conduct will be banned.

All posts and comments will be reviewed on a case-by-case basis. This means that some content that violates the rules may be allowed, while other content that does not violate the rules may be removed. The moderators retain the right to remove any content and ban users.


Lemmy World Partners

News !news@lemmy.world

Politics !politics@lemmy.world

World Politics !globalpolitics@lemmy.world


Recommendations

For Firefox users, there is media bias / propaganda / fact check plugin.

https://addons.mozilla.org/en-US/firefox/addon/media-bias-fact-check/

founded 1 year ago
MODERATORS
 

Doctors are hailing “off the chart” trial results that show a new drug stopped lung cancer advancing for longer than any other treatment in medical history.

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates in those with advanced forms of the disease, where tumours have spread, are particularly poor.

More than half of patients (60%) diagnosed with advanced forms of lung cancer who took lorlatinib were still alive five years later with no progression in their disease, data presented at the world’s largest cancer conference showed. The rate was 8% in patients treated with a standard drug, the trial found.

The results are the longest progression-free survival (PFS) outcomes ever recorded in patients with non-small cell lung cancer, the world’s most common form of the disease. They were presented at the annual meeting of the American Society of Clinical Oncology (Asco) in Chicago on Friday.

top 21 comments
sorted by: hot top controversial new old
[–] quinacridone@lemmy.ml 54 points 5 months ago (1 children)

I don't normally comment on news posts, but in this instance, FUCK CANCER

Fuck cancer for stealing my brother from me, and for taking half my bf's lung

I seriously hopes this works for everyone out there living with this disease, and for their families, friends, the people who love them....

.....and also for everyone who has died too soon and missed their chance for survival. Their donation of tissue samples and furthering the cancer research that ultimately wouldn't help them, but will help the poor bastards that are diagnosed today and in the future...It is bitter sweet

Fuck cancer

[–] boydster@sh.itjust.works 14 points 5 months ago

Fuck cancer all the way. Every step further in stopping it is a win. And this seems like it might be a particularly great step.

[–] Dasus@lemmy.world 32 points 5 months ago
[–] Blizzard@lemmy.zip 18 points 5 months ago (1 children)

It's the second major medical breathrough this week. If they both turned out true, that would be incredible.

[–] febra@lemmy.world 5 points 5 months ago (2 children)
[–] LiamMayfair@lemmy.sdf.org 10 points 5 months ago

I think it was a promising treatment for type 2 diabetes.

[–] Uriel_Copy@lemmy.world 6 points 5 months ago

Effectively a cure for Diabetes I believe

[–] lady_maria@lemmy.world 12 points 5 months ago (1 children)

That's awesome to hear, but I'm sure it'll be unaffordable for many—if not most—people who need it... at least in the US. :(

[–] Burn_The_Right@lemmy.world 19 points 5 months ago

It's great news for Europe, though! I'm glad for them.

[–] HubertManne@kbin.social 9 points 5 months ago (1 children)

doctors further said that once the results where back on the charts it showed a beneficial effect.

[–] lauha@lemmy.one 1 points 5 months ago

I assumed their charts were showing real numbers and their numbers were imaginary.

[–] FlyingSquid@lemmy.world 7 points 5 months ago (3 children)

So... smoke 'em if you got 'em.

[–] catloaf@lemm.ee 18 points 5 months ago (1 children)

Smoking can also cause cancer in the larynx, mouth, pharynx, esophagus, pancreas, bladder, stomach, colon, rectum, liver, cervix, kidney, and blood. It's by no means a free pass.

[–] FlyingSquid@lemmy.world 9 points 5 months ago (1 children)
[–] catloaf@lemm.ee -1 points 5 months ago

Yes, I'm familiar with its origin.

[–] zcd@lemmy.ca 14 points 5 months ago
[–] billiam0202@lemmy.world 9 points 5 months ago

Well that's a hilarious tinfoil hat theory- that lung-cancer-fighting drugs are financed by Big Tobacco as a way for them to sell more cigarettes.

And honestly, is there anything more late-stage capitalism than "who cares if this activity causes you cancer; you can just take a pill to make it go away!"

-The above post was brought to you by Lucky Strikes, the cigarette that causes the most treatable form of cancer!

[–] Stardust@kbin.social 7 points 5 months ago* (last edited 5 months ago)

Lung cancer killed my pet and I imagine it killed many other people's pets too. Cancer also killed some of my other pets.

[–] Spitzspot@lemmings.world 5 points 5 months ago

Pfizer to the moon!

[–] autotldr@lemmings.world 4 points 5 months ago

This is the best summary I could come up with:


Doctors are hailing “off the chart” trial results that show a new drug stopped lung cancer advancing for longer than any other treatment in medical history.

The results are the longest progression-free survival (PFS) outcomes ever recorded in patients with non-small cell lung cancer, the world’s most common form of the disease.

“To our knowledge these results are unprecedented,” said the study’s lead author, Dr Benjamin Solomon, a medical oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia.

“You don’t need a magnifying glass to see the difference between these two drugs,” said Dr Julie Gralow, Asco’s chief medical officer.

Dr David Spigel, the chief scientific officer of the Sarah Cannon Research Institute in London, a world-leading clinical trials facility specialising in new therapies for cancer patients, welcomed the findings.

“Showcasing the power of cancer-growth blocker drugs, this study could present us with an effective way of stopping cancer in its tracks and preventing it from spreading to the brain.


The original article contains 639 words, the summary contains 161 words. Saved 75%. I'm a bot and I'm open source!

[–] Shardikprime@lemmy.world 0 points 5 months ago

As in good, right?

RIGHT?